Lupin Limited has informed the Exchange regarding a press release dated October 12, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Calcium, Magnesium,Potassium, and Sodium Oxybates Oral Solution.".
Lupin Limited has informed the Exchange regarding a press release dated October 12, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Calcium, Magnesium,Potassium, and Sodium Oxybates Oral Solution.".